Monoamine oxidase-A, serotonin and norepinephrine: synergistic players in cardiac physiology and pathology

J Neural Transm (Vienna). 2018 Nov;125(11):1627-1634. doi: 10.1007/s00702-018-1908-y. Epub 2018 Jul 24.

Abstract

The mitochondrial enzyme monoamine oxidase A (MAO-A) is widely distributed in neuronal, myocyte and non-myocyte cardiac compartments. After the demonstrations that both cardiac neuronal and extraneuronal MAO-A contribute to the degradation of norepinephrine and serotonin, several studies attempted to determine the impact of MAO-A activity in the control of local concentration of the two biogenic amines and in their receptor-mediated effects. From the 2000s, an additional mechanism of action of MAO-A has been proposed. Such mechanism involves hydrogen peroxide (H2O2) production during substrate degradation. This finding stimulated a growing interest on the role of MAO-A-dependent oxidative stress in cardiac pathophysiology. Altogether, the results obtained by different groups showed that MAO-A played a key role in the regulation of physiological cardiac function and in the development of acute and chronic heart diseases through two mechanisms: the regulation of substrate concentrations and the intracellular production of reactive oxygen species. In this review, we will give an overview of the major results on the role of MAO-A in the field of cardiac diseases.

Keywords: Ageing; Heart failure; Monoamine oxidase-A; Oxidative stress.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Heart Failure / metabolism*
  • Humans
  • Monoamine Oxidase / metabolism*
  • Myocardium / metabolism*
  • Norepinephrine / metabolism*
  • Oxidative Stress / physiology
  • Reactive Oxygen Species / metabolism
  • Serotonin / metabolism*

Substances

  • Reactive Oxygen Species
  • Serotonin
  • Monoamine Oxidase
  • Norepinephrine